| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.9M | +413.6% |
| R&D Expense | $38.0M | — |
| SG&A Expense | $30.6M | +87.9% |
| Operating Income | -$26.5M | +21.1% |
| Pre-tax Income | -$39.9M | +49.6% |
| Net Income | -$40.9M | +48.3% |
| EPS (Basic) | -$2.65 | +83.9% |
| EPS (Diluted) | -$2.65 | +83.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.2M | -60.2% |
| Current Assets | $18.3M | +35.3% |
| Total Assets | $156.6M | +242.7% |
| Current Liabilities | $63.0M | +1063.3% |
| Long-term Debt | $28.0M | +1300.0% |
| Total Liabilities | $103.8M | +1783.5% |
| Stockholders' Equity | $52.8M | +31.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.3M | +21.7% |
| Investing Cash Flow | -$83.4M | -252.2% |
| Financing Cash Flow | $84.9M | +74.8% |